Peter H. O'Donnell to Predictive Value of Tests
This is a "connection" page, showing publications Peter H. O'Donnell has written about Predictive Value of Tests.
Connection Strength
0.169
-
Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application. Pharmacogenomics J. 2021 12; 21(6):691-711.
Score: 0.144
-
Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients. Oncotarget. 2016 Jun 21; 7(25):38359-38366.
Score: 0.025